PDB47 Understanding the Implications of Incorporating the UKPDS Glycaemic Legacy Effect Into Evaluating the Cost-Effectiveness of Type 2 Diabetes Therapies
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.1350
https://www.valueinhealthjournal.com/article/S1098-3015(11)02912-3/fulltext
Section Title :
Diabetes/Endocrine Disorders
Section Order :
1303
First Page :
A480
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02912-3&doi=10.1016/j.jval.2011.08.1350